2017
OR51 Correlation of class II antibody development with acute cellular rejection and fibrosis in pediatric liver transplantation
Bow L, Ekong U, Morotti R, Antala S, Emre S. OR51 Correlation of class II antibody development with acute cellular rejection and fibrosis in pediatric liver transplantation. Human Immunology 2017, 78: 47. DOI: 10.1016/j.humimm.2017.06.057.Peer-Reviewed Original ResearchAcute cellular rejectionClass II DSAPediatric liver transplantationLiver transplantationCellular rejectionHLA antibodiesFibrosis scoreDe novo HLA antibodiesNovo HLA antibodiesSided p valueDiagnosis of antibodyWilcoxon rank sumContinuous variablesGraft dysfunctionMean fibrosisSinusoidal fibrosisGraft functionPost transplantRejection gradeAvailable biopsiesLiver dysfunctionPatient characteristicsAntibody levelsDSA developmentSpecificity of antibodies
2009
Chronic Rejection Preceded by Central Perivenulitis, Rapidly Ensuing After Liver Transplantation in a Pediatric Patient
Miloh T, Magid M, Iyer K, Kerkar N, Morotti R. Chronic Rejection Preceded by Central Perivenulitis, Rapidly Ensuing After Liver Transplantation in a Pediatric Patient. Seminars In Liver Disease 2009, 29: 134-138. PMID: 19235665, DOI: 10.1055/s-0029-1202551.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAlanine TransaminaseAntiviral AgentsAspartate AminotransferasesBiopsyChronic DiseaseEpstein-Barr Virus InfectionsGraft RejectionHepatolenticular DegenerationHumansImmunosuppressive AgentsLiverLiver TransplantationMaleReoperationTreatment OutcomeUp-RegulationVasculitisVenulesViral LoadConceptsCentral perivenulitisChronic rejectionLiver transplantationPolymerase chain reactionModerate acute cellular rejectionAcute cellular rejectionFulminant Wilson's diseaseAcute rejectionCellular rejectionEBV seroconversionImmunosuppressive treatmentLiver transaminasesLiver biopsyPediatric patientsAntiviral therapyCase reportNaive statusWilson's diseaseChain reactionTransplantationDiseaseWeeksSubsequent increaseRejectionImmunosuppression